Real-world treatment patterns and outcomes with trifluridine/tipiracil monotherapy or in combination with bevacizumab in metastatic colorectal cancer.

by Beth Weaving | May 31, 2025 | Presentations

ASCO Annual Meeting, 2025

Biomarker testing patterns among patients newly diagnosed with prostate cancer in a community oncology network

by Beth Weaving | Feb 13, 2025 | Presentations

ASCO Genitourinary Cancers Symposium 2025, Prostate Biomarkers Poster Session

A Unique Model: Partnership between Community Oncology and Pharma

by Beth Weaving | Jun 1, 2024 | ASCO, Presentations

ASCO Quality 2024, Poster Session

The association of timely comprehensive genomic profiling with precision oncology treatment use and patient outcomes in advanced non-small cell lung cancer

by Beth Weaving | Mar 7, 2024 | Presentations

JCO Precision Oncology, Volume 8 • 2024

Evaluation of the impact of a decision-support platform (Trapelo) on testing patterns for patients with advanced solid tumors 

by Beth Weaving | Oct 28, 2023 | Presentations

ASCO Quality 2023, Poster Session B

Innovative biomarker testing initiative in a community oncology setting 

by Beth Weaving | Oct 27, 2023 | ASCO, Presentations

ASCO Quality 2023, Poster Session A